Pancreas-Kidney Transplantations With Primary Bladder Drainage Followed by Enteric Conversion : Graft Survival and Outcomes

• Published in: Transplantation Vol. 85; no. 4; pp. 517 - 523
• Main Authors: MARANG-VAN DE MHEEN, Perla J, NIJHOF, Hugo W, KHAIROUN, Meriem, HAASNOOT, Ada, VAN DER BOOG, Paul J. M, BARANSKI, Andrzej G
• Format: Journal Article
• Language: English
• Published: Hagerstown, MD Lippincott 27-02-2008
• Subjects: Adult; Biological and medical sciences; Cadaver; Female; Fundamental and applied biological sciences. Psychology; Fundamental immunology; Graft Survival; Humans; Kidney Transplantation - methods; Kidney Transplantation - mortality; Male; Medical sciences; Middle Aged; Pancreas Transplantation - methods; Pancreas Transplantation - mortality; Retrospective Studies; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases; Survival Analysis; Tissue Donors - statistics & numerical data; Tissue, organ and graft immunology; Treatment Outcome; Urinary Bladder - surgery; Prognosis; Transplantation; Homotransplantation; Conversion; Survival; Kidney; Drainage; Drug conversion; Treatment; Urinary system; Combined surgery; Urinary bladder; Bypass; Primary; Evolution; Graft; Pancreas
• ISSN: 0041-1337; 1534-6080
• DOI: 10.1097/TP.0b013e31816361f7

In the Leiden University Medical Centre, a two-step approach is routinely used in simultaneous pancreas-kidney (SPK) transplantations: primary bladder drainage (BD) followed by elective enteric conversion. The rationale for this approach is to prevent the short-term disadvantages of primary enteric drainage (intra-abdominal abscesses, pancreas graft loss) and the long-term urological complications related to bladder drainage. Aim of the present study is to evaluate survival and (urological) complications of this approach compared to enteric drainage (ED).
Patient records of all 98 SPK transplantations in the period 1997-2004 were reviewed for complications during the initial hospitalization until 30 days after discharge, and to assess urological complications and graft survival until the last hospital visit. Median duration of follow-up was 4.3 years for pancreas graft survival, 4.7 years for kidney graft survival, and 4.8 years for patient survival.
Patient survival was significantly better in BD patients than in ED patients (chi2=9.89 P<0.01). Pancreas graft survival was also better in BD patients after adjustment for the longer pancreas warm ischemia time in BD patients (P=0.05). The survival rates in our patient population seem higher than reported by the International Pancreas Transplant Registry, particularly in BD patients. Urological complications occurred in nine BD patients (10.3%), comparable to the rates reported for enteric-drained grafts.
This two-step approach of SPK transplantation results in excellent survival rates, with urological complication rates comparable to those reported for enteric-drained grafts, and may thus be viewed as a safe and effective procedure of SPK transplantation.